THC Biomed Intl Ltd.

THC

CA87243W1032

Pharmaceuticals

Delayed Canadian Securities Exchange Other stock markets 17:55:44 31/01/2024 GMT			5-day change	1st Jan Change
0.02 ^CAD	-.--%		-.--%	-.--%

2023	THC Biomed Intl Ltd. Introduces Always Hi New Brand Catering to Maturing Cannabis Consumer Trends	CI
2023	Thc Biomed Intl Ltd. Launches New Summer Cannabis Product: Thc Kiss Strawberry Tangerine Gummies	CI

THC Biomed Intl Ltd. Announces Laine Temporarily Resigns as Director of the Company

September 28, 2020 at 01:36 pm

THC BioMed Intl Ltd. announced that Ms. Laine had temporarily resigned as a director of the Company while Health Canada completed a standard security clearance for directors.

Latest news about THC Biomed Intl Ltd.

THC Biomed Intl Ltd. Introduces Always Hi New Brand Catering to Maturing Cannabis Consumer Trends	12-08	CI
Thc Biomed Intl Ltd. Launches New Summer Cannabis Product: Thc Kiss Strawberry Tangerine Gummies	04/07/23	CI
THC Biomed Intl Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023	29/06/23	CI
THC Biomed Intl Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2023	03/04/23	CI
THC Biomed Intl Ltd. acquired 40% stake in THC BioMed Co. Ltd for $0.06 million.	02/04/23	CI
THC Biomed Intl Ltd. to Open First Medical Cannabis Dispensary in Asia	24/02/23	CI
THC Biomed Intl Ltd. Announces CBD KISS Mango Beverage Shot and CBD Biscuits Begin sales in Ontario	24/02/23	CI
THC Biomed Intl Ltd. Reports Earnings Results for the First Quarter Ended October 31, 2022	29/12/22	CI
THC Biomed Intl Ltd. Auditor Raises 'Going Concern' Doubt	23/11/22	CI
THC Biomed Intl Ltd. Reports Earnings Results for the Full Year Ended July 31, 2022	23/11/22	CI
THC Biomed Intl Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2022	29/06/22	CI
THC Biomed Intl Ltd. Announces Broker and Commercial Sales Agreement with World Wide Brands Limited	13/06/22	CI
THC Biomed Intl Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2022	01/04/22	CI
THC BioMed Intl Ltd. Announces Availability of THC KISS Cannabis Biscuits to Consumers Through Ontario Cannabis Store Online and Wholesale to Ontario Retail Stores	02/02/22	CI
THC Biomed Intl Ltd. Grants Licence by Overseas Government to Cultivate Cannabis for Medical and Scientific Use	27/01/22	CI
THC Biomed Intl Ltd. announced that it has received CAD 0.25 million in funding	06/01/22	CI
THC Biomed Intl Ltd. Reports Earnings Results for the First Quarter Ended October 31, 2021	29/11/21	CI
THC Biomed Intl Ltd. Auditor Raises 'Going Concern' Doubt	28/11/21	CI
THC Biomed Intl Ltd. Reports Earnings Results for the Full Year Ended July 31, 2021	28/11/21	CI
THC BioMed Intl Ltd. Announces Three New Products to be List and Sold through Ontario Cannabis Stores	24/09/21	CI
THC Biomed Intl Ltd. Receives Purchase Orders from 30 Dispensaries in the Province of Manitoba	23/09/21	CI
THC KISS Mango Beverage Shot Ships to BC Cannabis Stores	01/09/21	CI
THC BioMed Announces Shipment of THC KISS Cannabis Biscuits to BC Cannabis Stores	31/08/21	CI
THC BioMed Announces 2nd Shipment of THC KISS Cannabis Biscuits to Saskatchewan	26/08/21	CI
THC BioMed Announces Shipment of Kiss Mango Beverage Shot to Ontario Cannabis Stores	17/08/21	CI

THC Biomed Intl Ltd. is a Canada-based cannabis company. The Company is engaged in the production of medical and recreational cannabis. It is licensed to cultivate and sell dried, extract, edible and topical cannabis. The Company is also engaged in scientific research and the development of products and services, with patient safety as a guiding principle. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho).

Sector

Pharmaceuticals

Calendar

26/06/2024 - Q3 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Alternative Medicine

	1st Jan change	Capi.
THC BIOMED INTL LTD.	-.--%	2.41M
DONG-E-E-JIAO CO.,LTD.	+42.38%	6.26B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-15.86%	4.49B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+6.36%	3.29B
TASLY PHARMACEUTICAL GROUP CO., LTD	-11.28%	3.12B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-3.23%	2.5B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+45.24%	1.94B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-7.89%	1.68B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-0.98%	1.63B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-11.32%	1.56B

Alternative Medicine